Journal
OSTEOPOROSIS INTERNATIONAL
Volume 23, Issue -, Pages S881-S883Publisher
SPRINGER LONDON LTD
DOI: 10.1007/s00198-012-2168-6
Keywords
Anti-osteoporotic treatments; Bone remodeling; Osteoarthritis; Osteoporosis; Sub-chondral bone
Categories
Funding
- Servier
- Novartis
- Amgen
- MSD
- Roche
- Lilly
Ask authors/readers for more resources
Subchondral bone is involved in the development of osteoarthritis, with an excess in bone resorption at an early stage and increased bone formation thereafter. Experimental and observational studies suggest that acting on bone can change progression of osteoarthritis. Clinical prospective controlled studies failed to confirm this result. Appropriate identification of patients at high risk of developing cartilage deterioration is a key issue for the analysis of impact of treatments for osteoporosis on osteoarthritis progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available